| Metric | FY 2021 | Prior Q | FY 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $134M | — | — | — | — |
| Op. Income | $12M | — | — | — | — |
| Gross Margin | 65.0% | — | — | — | — |
| Net Margin | 2.4% | — | — | — | — |
| EPS (Diluted) | $0.64 | — | — | — | — |
| Free Cash Flow | $35M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $134M |
| Cost of Revenue | $47M |
| GROSS PROFIT | $87M |
| R&D Expenses | $10M |
| Selling & Marketing | $18M |
| General & Administrative | $46M |
| SG&A Expenses | $64M |
| Other Expenses | $0 |
| Operating Expenses | $75M |
| Cost & Expenses | $122M |
| OPERATING INCOME | $12M |
| Interest Income | $107.0K |
| Interest Expense | $8M |
| Other Income/Expenses | -$10M |
| INCOME BEFORE TAX | $2M |
| Income Tax Expense | -$971.0K |
| Net Income from Continuing Ops | $3M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $3M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $3M |
| D&A | $18M |
| EBIT | $10M |
| EBITDA | $28M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $134M |
| Cost of Revenue | $47M |
| GROSS PROFIT | $87M |
| R&D Expenses | $10M |
| Selling & Marketing | $18M |
| General & Administrative | $46M |
| SG&A Expenses | $64M |
| Other Expenses | $0 |
| Operating Expenses | $75M |
| Cost & Expenses | $122M |
| OPERATING INCOME | $12M |
| Interest Income | $107.0K |
| Interest Expense | $8M |
| Other Income/Expenses | -$10M |
| INCOME BEFORE TAX | $2M |
| Income Tax Expense | -$971.0K |
| Net Income from Continuing Ops | $3M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $3M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $3M |
| D&A | $18M |
| EBIT | $10M |
| EBITDA | $28M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $3M |
| Depreciation & Amortization | $18M |
| Stock-Based Compensation | $9M |
| Deferred Income Tax | -$4M |
| Other Non-Cash Items | $5M |
| Change in Working Capital | $5M |
| OPERATING CASH FLOW | $37M |
| Capital Expenditure | -$2M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$2M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$3M |
| Other Financing Activities | $3M |
| NET CASH FROM FINANCING | $146M |
| FREE CASH FLOW | $35M |
| Net Change in Cash | $182M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $264M |
| Short-Term Investments | $0 |
| Net Receivables | $24M |
| Inventory | $11M |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $304M |
| PP&E (Net) | $22M |
| Goodwill | $161M |
| Intangible Assets | $112M |
| Long-Term Investments | $0 |
| Tax Assets | $616.0K |
| Other Non-Current Assets | $3M |
| TOTAL NON-CURRENT ASSETS | $298M |
| TOTAL ASSETS | $601M |
| Account Payables | $4M |
| Short-Term Debt | $0 |
| Deferred Revenue | $9M |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $33M |
| Long-Term Debt | $146M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $16M |
| Other Non-Current Liabilities | $715.0K |
| TOTAL NON-CURRENT LIABILITIES | $163M |
| TOTAL LIABILITIES | $195M |
| Common Stock | $318M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $72M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $16M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $406M |
| Minority Interest | $0 |
| TOTAL EQUITY | $406M |
| TOTAL LIABILITIES & EQUITY | $601M |
| Total Debt | $147M |
| Net Debt | -$117M |
